FDA
-
-
-
-
-
-
-
Motus GI Holdings (MOTS) Receives FDA Clearance to Commercialize Pure-Vu EVS Gastro and Gen 4 Colon
-
-
-
-
-
-
-
Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors
-
-
-
-
-
-
-
Motus GI Holdings (MOTS) Appoints Ravit Ram as CFO
-
-
-
-
-
-
-
Motus GI Reports Fourth Quarter and Full Year 2022 Financial ResultsĀ and Provides Corporate Update
-
-
-
-
-
-
-
Motus GI to Host Innovation Day Highlighting the Pure-Vu EVS System
-
-
-
-
-
-
-
Motus GI Reports First Quarter 2021 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Motus GI Announces First Patient Enrolled in a Pilot Study Using the Pure-VuĀ® System for Patients with Lower GI Bleeding Being Conducted by a Leading U.S. Medical Center
-
322,086 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

